A South Korean lettuce variety called heukharang or black harang, which serves as a natural treatment for insomnia is set for cultivation in Australia.
Jeollanamdo Agricultural Research & Extension Services (JARES) developed heukharang, which contains 3.74 milligrams of sleep-inducing lactucin per gram, or 124 times more than regular lettuce.
As the lactucin in regular lettuce is not potent enough to counter insomnia, an adult weighing 60 kilograms would need to consume 4 kilograms of it to induce sleep.
Heukharang would require much less consumption to achieve the desired results.
According to JARES, the Korean chemical firm Isu Chemical Co. has agreed to produce and sell heukharang lettuce in Australia.
Since Australia has strict quarantine laws for imported food but allows the importation of seeds, Isu Chemical Co. has to cultivate heukharang in Australia.
With its high gross national income and high prevalence of adult sleep disorders., Australia is a promising market for high-value-added and functional vegetables like heukharang.
Meanwhile. South Korea's market for insomnia treatment was estimated to be worth 40 billion won in 2020 and has been expanding at more than 5 percent annually.


Disaster or digital spectacle? The dangers of using floods to create social media content
France Battles Mediterranean Wildfires as Heatwave Fuels Fire Risk
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
Britain has almost 1 million young people not in work or education – here’s what evidence shows can change that
European Regulators Clash With U.S. Treasury Over Private Credit Transparency
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
BOJ May Raise Japan Growth Forecast While Keeping Focus on Inflation Risks
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
Stuck in a creativity slump at work? Here are some surprising ways to get your spark back
Gold Prices Set for Weekly Loss as Iran Tensions and Fed Rate Outlook Weigh
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
6 simple questions to tell if a ‘finfluencer’ is more flash than cash
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
Google promotes ‘teacher approved’ apps for kids. Here’s what parents should know 



